Study to Assess Change in Disease Activity of Risankizumab Treatment in Japanese Participants With Moderate to Severe Ulcerative Colitis
Clinical trial NCT07136116 · RECRUITING
Trial details
- NCT number
- NCT07136116
- Sponsor
- AbbVie
- Status
- RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2025-10-09
- Primary completion
- 2030-02-01
- Enrollment
- 200
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.